Haptoglobin Attenuates Cerebrospinal Fluid Hemoglobin-Induced Neurological Deterioration in Sheep
Translational Stroke Research · 2025-06 · 16 (3) · 728-732
DOI: 10.1007/s12975-024-01254-9 ↗Kurz gefasst
Fachartikel in der Zeitschrift Translational Stroke Research, online erschienen am 23.04.2024. Verfasst von Bart R Thomson und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurosurgery, Clinical Neuroscience Center, Universitätsspital and University of Zurich, Zurich, Switzerland. Hauptthemen laut MEDLINE: Haptoglobins, Hemoglobins, Subarachnoid Hemorrhage. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 9 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung, Innosuisse - Schweizerische Agentur für Innovationsförderung, Uniscientia Foundation.
Abstract (Originalsprache)
Secondary brain injury (SBI) occurs with a lag of several days post-bleeding in patients with aneurysmal subarachnoid hemorrhage (aSAH) and is a strong contributor to mortality and long-term morbidity. aSAH-SBI coincides with cell-free hemoglobin (Hb) release into the cerebrospinal fluid. This temporal association and convincing pathophysiological concepts suggest that CSF-Hb could be a targetable trigger of SBI. However, sparse experimental evidence for Hb’s neurotoxicity in vivo defines a significant research gap for clinical translation. We modeled the CSF-Hb exposure observed in aSAH patients in conscious sheep, which allowed us to assess neurological functions in a gyrencephalic species. Twelve animals were randomly assigned for 3-day bi-daily intracerebroventricular (ICV) injections of either Hb or Hb combined with the high-affinity Hb scavenger protein haptoglobin (Hb-Hp, CSL888). Repeated CSF sampling confirmed clinically relevant CSF-Hb concentrations. This prolonged CSF-Hb exposure over 3 days resulted in disturbed movement activity, reduced food intake, and impaired observational neuroscores. The Hb-induced neurotoxic effects were significantly attenuated when Hb was administered with equimolar haptoglobin. Preterminal magnetic resonance imaging (MRI) showed no CSF-Hb-specific structural brain alterations. In both groups, histology demonstrated an inflammatory response and revealed enhanced perivascular histiocytic infiltrates in the Hb-Hp group, indicative of adaptive mechanisms. Heme exposure in CSF and iron deposition in the brain were comparable, suggesting comparable clearance efficiency of Hb and Hb-haptoglobin complexes from the intracranial compartment. We identified a neurological phenotype of CSF-Hb toxicity in conscious sheep, which is rather due to neurovascular dysfunction than structural brain injury. Haptoglobin was effective at attenuating CSF-Hb-induced neurological deterioration, supporting its therapeutic potential.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neurosurgery, Clinical Neuroscience Center, Universitätsspital and University of Zurich, Zurich, Switzerland.
- Division of Internal Medicine, Universitätsspital and University of Zurich, Zurich, Switzerland.
- Neurology Service, Department of Small Animals, Vetsuisse Faculty, University of Zurich, Zurich, Switzerland.
- CSL Biologics Research Centre, Swiss Institute for Translational and Entrepreneurial Medicine, CSL, sitem-insel, Bern, Switzerland.
- Veterinary Anaesthesia Services - International, Winterthur, Switzerland.
- Center for Applied Biotechnology and Molecular Medicine (CABMM), University of Zurich, Zurich, Switzerland.
Förderung
- Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung
- Innosuisse - Schweizerische Agentur für Innovationsförderung
- Uniscientia Foundation
- University of Zurich
Zitieren
APA
Thomson, B. R., Schwendinger, N., Beckmann, K., Gentinetta, T., Couto, D., Wymann, S., Verdon, V., Buzzi, R. M., Akeret, K., Kronen, P. W., Weinberger, E. M., Held, U., Seehusen, F., Richter, H., Schaer, D. J., & Hugelshofer, M. (2025). Haptoglobin Attenuates Cerebrospinal Fluid Hemoglobin-Induced Neurological Deterioration in Sheep. Translational Stroke Research, 16(3), 728-732. https://doi.org/10.1007/s12975-024-01254-9
Vancouver
Thomson BR, Schwendinger N, Beckmann K, Gentinetta T, Couto D, Wymann S, et al. Haptoglobin Attenuates Cerebrospinal Fluid Hemoglobin-Induced Neurological Deterioration in Sheep. Translational Stroke Research. 2025;16(3):728-732. doi:10.1007/s12975-024-01254-9
BibTeX
@article{Thomson2025,
author = {Thomson, Bart R and Schwendinger, Nina and Beckmann, Katrin and Gentinetta, Thomas and Couto, Daniel and Wymann, Sandra and Verdon, Valérie and Buzzi, Raphael M and Akeret, Kevin and Kronen, Peter W and Weinberger, Eva M and Held, Ulrike and Seehusen, Frauke and Richter, Henning and Schaer, Dominik J and Hugelshofer, Michael},
title = {Haptoglobin Attenuates Cerebrospinal Fluid Hemoglobin-Induced Neurological Deterioration in Sheep},
journal = {Translational Stroke Research},
year = {2025},
volume = {16},
number = {3},
pages = {728--732},
doi = {10.1007/s12975-024-01254-9}
}
EUVIMED